NIMS Gets FDA Grants OK to Expand Exer-Rest Indications to Include ... - Trading Markets (press release)

NIMS Gets FDA Grants OK to Expand Exer-Rest Indications to Include ... Trading Markets (press release), CA Morning stiffness is also prevalent in osteoarthritis, polymyalgia rheumatica, ankylosing spondylitis, psoriatic arthritis, and Achilles tendonopathy. A home interview survey conducted by others in over 4000 persons above age 55 years revealed the ...

Five-Year Data Demonstrate Initial Use of Abbott's HUMIRA ... - Insciences Organisation

Five-Year Data Demonstrate Initial Use of Abbott's HUMIRA ... Insciences Organisation, Switzerland HUMIRA is a fully human monoclonal antibody approved for the treatment of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), moderate to severe chronic plaque psoriasis, active ankylosing spondylitis (AS), moderate to severe ...

It matters to this one - May 30 - Examiner.com

Examiner.com

It matters to this one - May 30 Examiner.com Web site: www.clinicaltrials.gov Ankylosing Spondylitis. All study-related tests are provided at no cost. Call 866-444-2214 or TTY 1-866-411-1010. Web site: www.clinicaltrials.gov Prince George's County Health Department - The Addictions & Mental ...

Reumatologia - postępy 2008 - Medycyna Praktyczna

Reumatologia - postępy 2008 Medycyna Praktyczna, Poland Golimumab, a new human anti-TNF-alpha monoclonal antibody administered subcutaneously every 4 weeks, improves anemia and well-being in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis. Ann. Rheum. Dis., 2008; 67 (supl. ...